100
Participants
Start Date
March 5, 2021
Primary Completion Date
May 1, 2021
Study Completion Date
May 1, 2021
dexmedetomidine combined with midazolam and remifentanil.
Patients in this group will receive a bolus of midazolam 0.03 mg/kg intravenously, and then a loading dose of 0.5 mcg/kg remifentanil and 0.5 mcg/kg dexmedetomidine over 5 min via separate syringe pumps.
propofol combined with midazolam and remifentanil.
Patients in this group will receive a bolus of midazolam 0.03 mg/kg intravenously, and then a loading dose of 0.5 mcg/kg remifentanil and 0.33 mg/kg propoful over 5 min via separate syringe pumps.
the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou
Sixth Affiliated Hospital, Sun Yat-sen University
OTHER